ELF3 and non-small cell lung carcinoma: ELF3 mutations were uncommon in NSCLC, with a 1.4% mutation incidence in The Cancer Genome Atlas (TCGA) cohort (n = 408) (Supplementary Fig. 1a) and 1.0% in COSMIC v84 (n = 1302).